Stockscreener 앱 받기
4.00
5.44%
-0.23
시장 영업 전:
4.20
0.20
+5.00%
Diamedica Therapeutics Inc (DMAC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Research and Development |
0.03%
3.676
|
3.677 | 3.272 | 2.543 | 3.618 |
| Operating Income/Loss |
1.83%
-5.741
|
-5.848 | -5.157 | -4.741 | -5.521 |
| Income/Loss From Continuing Operations Before Tax |
0.10%
-5.144
|
-5.139 | -4.464 | -4.47 | -5.265 |
| Income Tax Expense/Benefit |
68.18%
0.007
|
0.022 | 0.007 | 0.007 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
0.19%
-5.151
|
-5.161 | -4.471 | -4.477 | -5.272 |
Net Income/Loss
|
0.19%
-5.151
|
-5.161 | -4.471 | -4.477 | -5.272 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,991%
37.96
|
1.8154 | 37.95 | 27.31 | 26.45 |
| Basic Earnings Per Share |
0.00%
-0.14
|
-0.14 | -0.12 | -0.16 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.39%
3.66%
자본화:
|
볼륨(24시간):